D. Foedinger et al., AUTOANTIBODIES TO DESMOPLAKIN-I AND DESMOPLAKIN-II IN PATIENTS WITH ERYTHEMA-MULTIFORME, The Journal of experimental medicine, 181(1), 1995, pp. 169-179
Erythema multiforme (EM) represents a syndrome of chronic recurrent in
flammatory skin disease. Depending on the severity and extent of skin
and mucosal involvement, it is defined either as EM minor or EM major.
In this study we demonstrate the presence of autoantibodies (aAbs) ag
ainst desmoplakin I and II, two major proteins of the desmosomal plaqu
e, in six of six patients with the severe variant of EM, EM major. Lig
ht microscopic studies of lesional skin and mucous membranes localized
in vivo bound immunoglobulin G (IgG) in a dotted desmosomal pattern a
long the cytoplasmic membranes of keratinocytes. By immunoelectronmicr
oscopy, in vivo bound IgG was confined to the desmosomal plaques. Thes
e findings were confirmed by indirect immunolocalization studies that
demonstrated the presence of IgG aAbs in the serum of patients during
active disease. These aAbs did not only bind to desmosomal plaques of
epithelial cells where they colocalized with defined murine monoclonal
antibodies directed against desmoplakin I and II, but also labeled th
e intercalated discs of myocardial cells. Biochemical characterization
of circulating IgG aAbs revealed desmoplakin I and II as actual targe
t autoantigens. By passive transfer of serum into newborn mice, in viv
o binding of serum aAbs to keratinocytes was shown. The findings prese
nted in this study imply a humoral immune response in certain patients
with EM major and indicate a potential pathogenetic role of aAbs agai
nst desmoplakin I and II in this disease.